Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Robert Sidbury, Dawn M Davis, David E Cohen, Kelly M Cordoro, Timothy G Berger, James N Bergman, Sarah L Chamlin, Kevin D Cooper, Steven R Feldman, Jon M Hanifin, Alfons Krol, David J Margolis, Amy S Paller, Kathryn Schwarzenberger, Robert A Silverman, Eric L Simpson, Wynnis L Tom, Hywel C Williams, Craig A Elmets, Julie Block, Christopher G Harrod, Wendy Smith Begolka, Lawrence F Eichenfield
Index: J. Am. Acad. Dermatol. 71(2) , 327-49, (2014)
Full Text: HTML
Abstract
Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.Copyright © 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Related Compounds
Related Articles:
2014-12-01
[Plast. Reconstr. Surg. 134(6) , 1213-23, (2014)]
2014-09-01
[Am. J. Physiol. Cell Physiol. 307(5) , C479-92, (2014)]
2014-09-01
[Arch. Toxicol. 88(9) , 1695-709, (2014)]
2014-01-01
[PLoS ONE 9(11) , e112413, (2014)]
2014-09-01
[Cell Biochem. Biophys. 70(1) , 367-81, (2014)]